Literature DB >> 9238616

Epidemiology of renal-cell carcinoma.

A Tavani1, C La Vecchia.   

Abstract

Renal-cell cancer is responsible for about 2% of all cancer deaths in developed countries and represents 80-85% of all tumors of the kidney. Its etiology is still largely undefined. Recently the results of a large international population-based case-control study (International Renal-Cell Cancer Study), conducted between 1989 and 1991 in Australia, Denmark, Germany, Sweden and USA, including 1732 cases and 2309 controls, showed an increased risk of renal-cell cancer in relation to tobacco smoking, elevated body mass index, a few medical conditions, the use of beta-blockers, a family history of the disease, high intake of dairy products and low intake of fruit and vegetables and, in women, multiparity. Most other studies agree about a causal role of cigarette smoking in the etiology of renal-cell cancer, although its association is less strong than for several other tobacco-related neoplasms, with a relative risk of about 2 for current smokers. Other established risk factors are elevated body mass index (mainly in women) and a family history of the disease. Occupational exposure to chemicals appears to have little significance, although associations with specific products, such as asbestos fibres, have been reported. Some relationship has been observed between renal-cell cancer and hypertension, use of anti-hypertensives and kidney diseases, although this issue remains open to discussion. Data are inconsistent on the role of nutrition, mainly for fats and proteins, while vegetable and fruit consumption seems to convey some protection on renal-cell cancer risk. The risk of renal-cell cancer was not materially elevated in relation to coffee, tea and alcohol intake and, in women, oral contraceptive use, hormone replacement therapy, and menstrual factors.

Entities:  

Mesh:

Year:  1997        PMID: 9238616

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  11 in total

Review 1.  Aspirin and urologic cancer risk: an update.

Authors:  Cristina Bosetti; Valentina Rosato; Silvano Gallus; Carlo La Vecchia
Journal:  Nat Rev Urol       Date:  2012-01-24       Impact factor: 14.432

2.  Dietary Inflammatory Index and Renal Cell Carcinoma Risk in an Italian Case-Control Study.

Authors:  Nitin Shivappa; James R Hébert; Valentina Rosato; Marta Rossi; Maurizio Montella; Diego Serraino; Carlo La Vecchia
Journal:  Nutr Cancer       Date:  2017-07-18       Impact factor: 2.900

3.  Occupational risk factors for kidney cancer: a cohort study in Sweden.

Authors:  Jianguang Ji; Charlotta Granström; Kari Hemminki
Journal:  World J Urol       Date:  2005-11-08       Impact factor: 4.226

4.  Distribution of polyunsaturated fatty acids including conjugated linoleic acids in total and subcellular fractions from healthy and cancerous parts of human kidneys.

Authors:  Kristina Hoffmann; Jörg Blaudszun; Claus Brunken; Wilhelm-Wolfgang Höpker; Roland Tauber; Hans Steinhart
Journal:  Lipids       Date:  2005-03       Impact factor: 1.880

5.  Oncogenic microRNA-142-3p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.

Authors:  Yifan Li; Duqun Chen; L U Jin; Jiaju Liu; Yuchi Li; Zhengming Su; Zhengyu Qi; Min Shi; Zhimao Jiang; Shangqi Yang; Yaoting Gui; Xiangming Mao; Xionghui Wu; Yongqing Lai
Journal:  Oncol Lett       Date:  2015-12-10       Impact factor: 2.967

6.  Lipid class distribution of fatty acids including conjugated linoleic acids in healthy and cancerous parts of human kidneys.

Authors:  Kristina Hoffmann; Jörg Blaudszun; Claus Brunken; Wilhelm-Wolfgang Höpker; Roland Tauber; Hans Steinhart
Journal:  Lipids       Date:  2005-10       Impact factor: 1.880

7.  Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model.

Authors:  Kazim Sahin; Brian Cross; Nurhan Sahin; Karina Ciccone; Shadeah Suleiman; Adeboye O Osunkoya; Viraj Master; Wayne Harris; Bradley Carthon; Ramzi Mohammad; Birdal Bilir; Karin Wertz; Carlos S Moreno; Cheryl L Walker; Omer Kucuk
Journal:  Arch Biochem Biophys       Date:  2015-01-17       Impact factor: 4.013

8.  Clinical outcomes and survival of advanced renal cancer patients in phase I clinical trials.

Authors:  Laeeq Malik; Helen Parsons; Devalingam Mahalingam; Benjamin Ehler; Martin Goros; Alex Mejia; Andrew Brenner; John Sarantopoulos
Journal:  Clin Genitourin Cancer       Date:  2014-02-04       Impact factor: 2.872

9.  Renal tumors and second primary pancreatic tumors: a relationship with clinical impact?

Authors:  Sascha A Müller; Sascha Pahernik; Ulf Hinz; David J Martin; Moritz N Wente; Thilo Hackert; Christine Leowardi; Axel Haferkamp; Markus W Büchler; Bruno M Schmied
Journal:  Patient Saf Surg       Date:  2012-08-08

Review 10.  Meta-analysis of the diagnostic performance of [18F]FDG-PET and PET/CT in renal cell carcinoma.

Authors:  Hsin-Yi Wang; Hueisch-Jy Ding; Jin-Hua Chen; Chih-Hao Chao; Yu-Yu Lu; Wan-Yu Lin; Chia-Hung Kao
Journal:  Cancer Imaging       Date:  2012-10-26       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.